On December 24, Cao Chengzhi, Global Vice President and General Manager of China (Group) of Halogen, Xu Hongzhuang, Director of Diagnostic and Surgery Business of Halogen China, and Yao Xiaohua, Manager of Central China of Halogen, came to our company for discussions and exchanges. Qiu Xuewen, general manager of Wuhan Half the Sky, and relevant leaders received the reception. The two parties discussed the details of future cooperation and reached a series of strategic consensus.
Halogen is a multinational medical technology company that was listed on Nasdaq in 1990. It is committed to the research and development, production and promotion of advanced diagnostic products, medical imaging systems and surgical products to meet women’s medical and health needs. It is the first medical company to introduce breast tomographic imaging technology to the market, and provides advanced technologies and comprehensive solutions from screening, diagnosis and treatment of breast and bone diseases to the world.
Wuhan Half the Sky and Haoluojie are both innovative medical companies with core technologies and have long been committed to the development of women’s health. During this visit, Cao Chengzhi, global vice president of Haoluojie and general manager of China (Group), and his delegation focused on visiting Bantiantian’s minimally invasive gynecological products and breast rotation products. The general manager of Wuhan Bantiantian explained in detail and performed operational demonstrations.
Subsequently, the two parties held discussions and exchanges on future cooperation and jointly discussed how to better serve the development of women’s health.
Qiu Xuewen, General Manager of Wuhan Half the Sky, extended a warm welcome to Cao Chengzhi, Global Vice President and General Manager of China (Group) of Haloje, and his delegation. He said that Wuhan Half the Sky and Haloje are both socially responsible companies and have a lot of room for cooperation in minimally invasive solutions for gynecology and breast. He hoped that the two parties could further clarify cooperation details, reach strategic consensus through this negotiation, and build a new win-win situation based on the previous friendly negotiations.
The two parties had an in-depth discussion on the details of the cooperation. Wuhan Bantian Tian and Haoluojie Company agreed that future cooperation should be driven by technological innovation and market demand-oriented to promote the development of women’s health in the fields of gynecology and breast surgery. The two parties also exchanged views on the expansion of the international market and reached a series of strategic consensuses.
Cao Chengzhi, global vice president of Haoluojie and general manager of China (Group), highly recognized Wuhan Half the Sky’s minimally invasive products. He said that through this negotiation, he saw Half the Sky’s profound accumulation and outstanding achievements in the field of women’s health. He is full of confidence and expectations for future cooperation. He hopes that both parties can give full play to each other’s advantages and bring good news to the majority of patients with gynecological and breast diseases.
With the joint efforts of both parties, this negotiation has made great progress and laid a solid foundation for subsequent cooperation between the two parties. We believe that this strategic cooperation will bear fruitful results and bring better health and well-being to women around the world!
Wuhan Half the Sky has been committed to the research and development of minimally invasive radio frequency technology for more than 20 years. We will take this opportunity to adhere to the mission of “healthy half the sky and benefit all mankind”, continue to deepen the innovation of minimally invasive medical technology, and continuously improve and polish the quality and service quality, striving to create more minimally invasive medical products that lead the world trend!